NimbleGen Sequence Capture 385K array identifies gene mutations linked with hereditary hearing loss

Hereditary hearing loss is the most common sensory disorder in humans. A German research team led by Ingo Kurth from the Institute of Human Genetics at the University Hospital Jena, Germany, used a number of different methods, including Roche's NimbleGen Custom Sequence Capture 385K array to identify the gene mutated in the disease locus of the X-chromosome of a Spanish family with hereditary ...

Health happenings: Jan. 31

Send information about free or low-cost health-related events open to the public 10 days ahead of publication. Information can be emailed to jmorreale@bradenton.com.

Health happenings: Jan. 10

Send information about free or low-cost health-related events open to the public 10 days ahead of publication. Information can be emailed to jmorreale@bradenton.com.

214 New Laws Take Effect Jan. 1, 2012

More than 200 new laws, covering everything from local library boards to murder, will take effect Jan. 1.

FDA Approves Erivedge (vismodegib) Capsule, The First Medicine For Adults With Advanced Basal Cell Carcinoma

Roche recently announced that Erivedge (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for adults with a type of skin cancer, called basal cell carcinoma (BCC), that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation.